These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10469805)

  • 1. Optimal sampling theory: An overview of its application to pharmacokinetic studies in infants and children.
    Reed MD
    Pediatrics; 1999 Sep; 104(3 Pt 2):627-32. PubMed ID: 10469805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pediatric pharmacology: is treatment of children preceded by an adequate investigation?].
    Rubio González A; Suárez Ochoa J; Azanza Perea J; Honorato Pérez J
    An Esp Pediatr; 1989 May; 30(5):359-62. PubMed ID: 2667410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug development in pediatrics: problems and strategies. The point of view of the academic community.
    Soyka LF
    Pediatr Pharmacol (New York); 1980; 1(1):21-4. PubMed ID: 7346728
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in paediatric pharmacokinetics.
    Knibbe CA; Krekels EH; Danhof M
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):1-8. PubMed ID: 21117982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European regulatory authorities and pediatric labeling.
    Autret E
    Pediatrics; 1999 Sep; 104(3 Pt 2):614-8. PubMed ID: 10469802
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges in providing pharmaceutical care to pediatric patients.
    Zenk KE
    Am J Hosp Pharm; 1994 Mar; 51(5):688-94. PubMed ID: 8203392
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in pediatric pharmacology and toxicology.
    Berlin CM
    Adv Pediatr; 1995; 42():593-629. PubMed ID: 8540440
    [No Abstract]   [Full Text] [Related]  

  • 8. Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary.
    Pandolfini C; Bonati M
    Arch Dis Child; 2008 Aug; 93(8):715. PubMed ID: 18644943
    [No Abstract]   [Full Text] [Related]  

  • 9. [Computer simulations to support drug therapy in children].
    Breddemann A; Läer S
    Med Monatsschr Pharm; 2008 Nov; 31(11):429-33. PubMed ID: 19055162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population approaches in paediatrics.
    Chatelut E
    Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curvature-adjusted optimal design of sampling times for the inference of pharmacokinetic compartment models.
    Daimon T; Goto M
    Stat Med; 2007 Jun; 26(14):2799-812. PubMed ID: 17072822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drugs in pediatrics using K-PD models: perspectives.
    Tod M
    Fundam Clin Pharmacol; 2008 Dec; 22(6):589-94. PubMed ID: 19049659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
    Bouzom F; Walther B
    Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics/pharmacodynamics in drug development: an industrial perspective.
    Chaikin P; Rhodes GR; Bruno R; Rohatagi S; Natarajan C
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1428-38. PubMed ID: 11185663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric clinical trial experience: government, child, parent and physician's perspective.
    Salazar JC
    Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial treatment length optimization with an emphasis on disease progression studies.
    Hennig S; Nyberg J; Hooker AC; Karlsson MO
    J Clin Pharmacol; 2009 Mar; 49(3):323-35. PubMed ID: 19246730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-drug interaction implications in pediatric practice: an overview of pharmacokinetic trials.
    Johnston BC; Wu P; Mills E
    Arch Pediatr Adolesc Med; 2005 Jul; 159(7):692. PubMed ID: 15997009
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic considerations in neonatal drug therapy.
    Guyon G
    Neonatal Netw; 1989 Apr; 7(5):9-12. PubMed ID: 2704357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.